GoAI
Get started
Human Metabolome Technologies, Inc. logo

Human Metabolome Technologies, Inc.

6090.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥624

+¥12.00 · +1.96%

Aug 24, 2:36 PM JST

6090.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Yasuhiro Ohata
Listed since
Dec 24, 2013
Employees
62

Market position

Day range

Current ¥624

52-week range

Current ¥624

Open
¥613
Previous close
¥612
Volume
8.4K
1.04× average
Average volume
8.08K
Average daily volume
Market cap
3.47B JPY
Beta
1.5
Market reference 1
50-day average
¥606.44
+2.90% above average
200-day average
¥661.98
-5.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.1B JPY
P/E (TTM)
17.24×
P/B (TTM)
1.86×
P/S (TTM)
2.44×
EV / EBITDA
6.55×
Earnings yield
5.82%
Free cash flow yield
4.31%
Dividend yield
2.88%

Profitability & efficiency

Gross margin
61.08%
Operating margin
14.76%
Net margin
14.09%
Return on equity
10.95%
Return on assets
8.79%
Return on invested capital
9.63%

Financial health

Debt / equity
0.06×
Current ratio
4.03×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends74%52%30%9%Gross margin, FY2021: 68.67%Gross margin, FY2022: 66.17%Gross margin, FY2023: 64.60%Gross margin, FY2024: 63.37%Gross margin, FY2025: 61.08%Operating margin, FY2021: 15.63%Operating margin, FY2022: 16.24%Operating margin, FY2023: 16.36%Operating margin, FY2024: 17.11%Operating margin, FY2025: 14.76%Net margin, FY2021: 21.89%Net margin, FY2022: 21.99%Net margin, FY2023: 18.08%Net margin, FY2024: 17.59%Net margin, FY2025: 14.09%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 68.67%. Gross margin FY2022 66.17%. Gross margin FY2023 64.60%. Gross margin FY2024 63.37%. Gross margin FY2025 61.08%. Operating margin FY2021 15.63%. Operating margin FY2022 16.24%. Operating margin FY2023 16.36%. Operating margin FY2024 17.11%. Operating margin FY2025 14.76%. Net margin FY2021 21.89%. Net margin FY2022 21.99%. Net margin FY2023 18.08%. Net margin FY2024 17.59%. Net margin FY2025 14.09%.

Income trends

Revenue

1.42B JPY-2.27%

Operating income

209.91M JPY-15.70%

Net income

200.36M JPY-21.74%
Income trends across reported periods1.58B JPY1.08B JPY570.31M JPY64.77M JPYRevenue, FY2021: 1.22B JPYRevenue, FY2022: 1.3B JPYRevenue, FY2023: 1.35B JPYRevenue, FY2024: 1.46B JPYRevenue, FY2025: 1.42B JPYOperating income, FY2021: 191.15M JPYOperating income, FY2022: 210.98M JPYOperating income, FY2023: 220.17M JPYOperating income, FY2024: 249M JPYOperating income, FY2025: 209.91M JPYNet income, FY2021: 267.79M JPYNet income, FY2022: 285.76M JPYNet income, FY2023: 243.25M JPYNet income, FY2024: 256M JPYNet income, FY2025: 200.36M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.22B JPY. Revenue FY2022 1.3B JPY. Revenue FY2023 1.35B JPY. Revenue FY2024 1.46B JPY. Revenue FY2025 1.42B JPY. Operating income FY2021 191.15M JPY. Operating income FY2022 210.98M JPY. Operating income FY2023 220.17M JPY. Operating income FY2024 249M JPY. Operating income FY2025 209.91M JPY. Net income FY2021 267.79M JPY. Net income FY2022 285.76M JPY. Net income FY2023 243.25M JPY. Net income FY2024 256M JPY. Net income FY2025 200.36M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue1.42B JPY1.46B JPY1.35B JPY1.3B JPY1.22B JPY
Cost of goods sold553.42M JPY533M JPY476.34M JPY439.47M JPY383.28M JPY
Gross profit868.53M JPY922M JPY869.33M JPY859.75M JPY840.01M JPY
Research and development——146M JPY185M JPY158M JPY
Selling, general, and administrative658.61M JPY672M JPY457.91M JPY454M JPY486M JPY
Operating expenses658.61M JPY673M JPY649.16M JPY648.77M JPY648.85M JPY
Interest income2.76M JPY880K JPY14K JPY14K JPY11K JPY
Interest expense1.98M JPY2.49M JPY2.1M JPY2.27M JPY2.21M JPY
Depreciation and amortization111.35M JPY103M JPY86.32M JPY80.39M JPY64.9M JPY
Operating income209.91M JPY249M JPY220.17M JPY210.98M JPY191.15M JPY
Net income200.36M JPY256M JPY243.25M JPY285.76M JPY267.79M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
6.35

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates40.1119.62-0.86-21.34Q4 '24Q1 '25Q2 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 13, 2024: actual -5.99, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 21.73, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 35.87, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 30, 2025: actual -8.32, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual -17.11, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 24.84, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 21.61, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 6.35, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates613.33M462.43M311.54M160.65MQ4 '24Q1 '25Q2 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 13, 2024: actual 274M JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 410M JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 581.89M JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 30, 2025: actual 189M JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 192.38M JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 467M JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 448M JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 314M JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥15.00

2025 complete year+50.0% since 2023

2026 partial: ¥18.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Jun 29, 2027

¥18.00

Annual

Record Jun 30, 2027 · Payment Jun 29, 2027

Dividend

Ex-dividend Jun 29, 2026

¥18.00

Annual

Record Jun 30, 2026 · Payment Sep 3, 2026

Dividend

Ex-dividend Jun 27, 2025

¥15.00

Annual

Record Jun 30, 2025 · Payment Sep 4, 2025

Dividend

Ex-dividend Jun 27, 2024

¥15.00

Annual

Record Jun 30, 2024 · Payment Sep 5, 2024

Dividend

Ex-dividend Jun 29, 2023

¥10.00

Annual

Record Jun 30, 2023 · Payment Sep 7, 2023

6090.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

Continue in GoAI

Research 6090.T

research.disclaimer